Skip to main content
. Author manuscript; available in PMC: 2020 Apr 17.
Published in final edited form as: Vaccine. 2019 Mar 27;37(17):2322–2330. doi: 10.1016/j.vaccine.2019.03.044

Figure 3. IL-33 increases OVA-specific IgG and IgM.

Figure 3.

A. Immunization schedule. Mice (n=6 per group) received IL-33 (2.5 μg) i.p. and i.m. one week prior to and at time of i.m. immunization with ovalbumin protein (100 μg) in alum. Plasma OVA-specific IgG (B) and IgM (C) determined by ELISA. Symbols represent individual mice. * indicates significant difference (p<0.05) between groups as determined by two-tailed Mann-Whitney test. This experiment was conducted once.